Algernon Pharmaceuticals is a clinical-stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, and idiopathic pulmonary fibrosis. It utilizes a drug repurposing strategy discovering new therapeutic uses for existing drugs.